International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
American Red Cross Institute for the Blind Institution for the Blind. The Committee of Direction of the Red Cross Institute for the Blind was composed of five members, each appointed by the General Manager of the American Red Cross. American Red Cross Institute for the Blind Red Cross Institute for the Blind (also known as Evergreen) was established by the American Red Cross in 1917. It was located in Baltimore, Maryland. The institute furnished the connecting link between the military and civil life of the injured men. The Red Cross Institute for the Blind was organized at the request of the Surgeon General of the United States